Gambia probes suspected paracetamol syrup link to dozens of child deaths
"Dozens of children have died in the last three months," Bittaye told Reuters by phone. "Autopsies suggest the possibility of paracetamol.";
Banjul: Gambia's government is investigating whether the deaths of dozens of young children from kidney failure in recent months are linked to paracetamol syrup, the head of the country's health service said on Thursday.
A spike in cases of acute kidney injury among children under the age of five was detected in late July. As cases mounted, doctors began to suspect medicines could be involved.
Gambia's director of health services, Mustapha Bittaye, told Reuters that a number of patients began to fall ill with kidney problems three to five days after taking a paracetamol syrup sold locally. It was not yet clear if any particular brand of paracetamol, used by parents in many countries to treat fevers in children, was under investigation.
E. coli bacteria was also a possible cause, Bittaye said.
The children suffered symptoms including an inability to pass urine, fever and vomiting that quickly led to kidney failure.
By early August, 28 children had died, according to health ministry figures, with a fatality rate of nearly 90%. The number of fatalities is now much higher, said Bittaye.
An official updated tally is expected in the coming days.
Read also: No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.